Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRAP1 | Q12931 | 9/20 | 0.79 |
| ▸ | HSP90AA1 | P07900 | 6/20 | 0.79 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.79 |
| ▸ | HSP90B1 | P14625 | 5/20 | 0.55 |
| ▸ | ADORA2A | P29274 | 10/20 | 0.48 |
| ▸ | ADORA1 | P30542 | 10/20 | 0.48 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.45 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23416540 | 0.88 | TRAP1 (0.76) | TRAP1HSP90AA1HSP90AB1HSP90B1ADORA2A | |
| SCHEMBL20118754 | 0.88 | TRAP1 (1.00) | TRAP1HSP90AA1HSP90AB1HSP90B1ADORA2A | |
| SCHEMBL4452564 | 0.85 | HSP90AA1 (0.71) | TRAP1HSP90AA1HSP90AB1HSP90B1ADORA2A | |
| SCHEMBL29616933 | 0.84 | TRAP1 (0.70) | TRAP1HSP90AA1HSP90AB1HSP90B1ADORA2A | |
| SCHEMBL23388297 | 0.84 | TRAP1 (0.70) | TRAP1HSP90AA1HSP90AB1HSP90B1ADORA2A | |
| SCHEMBL29616980 | 0.84 | TRAP1 (0.62) | TRAP1HSP90AA1HSP90AB1HSP90B1ADORA2A | |
| SCHEMBL23388345 | 0.84 | TRAP1 (0.62) | TRAP1HSP90AA1HSP90AB1HSP90B1ADORA2A | |
| SCHEMBL20118687 | 0.83 | HSP90AA1 (0.68) | TRAP1HSP90AA1HSP90AB1HSP90B1ADORA2A | |
| SCHEMBL20118690 | 0.81 | TRAP1 (0.65) | TRAP1HSP90AA1HSP90AB1HSP90B1ADORA2A | |
| SCHEMBL20118709 | 0.81 | TRAP1 (0.65) | TRAP1HSP90AA1HSP90AB1HSP90B1ADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230159534-A1 | ADENOSINE RECEPTOR ANTAGONIST COMPOUNDS | ILDONG PHARMACEUTICAL CO., LTD. (KR) | 2023-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230159534-A1 | ADENOSINE RECEPTOR ANTAGONIST COMPOUNDS | ADORA2A, ADORA1, ADORA3 | TRAP1 1393/4885HSP90AA1 2208/4885HSP90AB1 1972/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.